Study of an Injectable Regimen of GS-3242 With Lenacapavir Compared to Biktarvy in People New to HIV-1 Treatment

GS-3242 TabletOngoingRecruitingPhase 2Open NCT07708727 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…

NCT07708727 · Trial Tracker · ComplyRx